<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04065464</url>
  </required_header>
  <id_info>
    <org_study_id>ZEG2019_01</org_study_id>
    <nct_id>NCT04065464</nct_id>
  </id_info>
  <brief_title>TRACY - Track My Cycle</brief_title>
  <acronym>TRACY</acronym>
  <official_title>TRACY - Track My Cycle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Center for Epidemiology and Health Research, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ava AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Center for Epidemiology and Health Research, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of the pilot study is to collect data for the fine-tuning and evaluation of
      the Ava algorithm. Secondary outcomes are the estimation of the accuracy in detecting the
      fertility status of each cycle day.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 3, 2019</start_date>
  <completion_date type="Actual">January 10, 2020</completion_date>
  <primary_completion_date type="Actual">December 20, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fine-tuning Ava algorithm</measure>
    <time_frame>5 months</time_frame>
    <description>Number of days within a menstrual cycle that are correctly predicted as 'fertile' by the Ava algorithm.
Number of study participants who have their 'fertile window' accurately predicted by the Ava AG app.</description>
  </primary_outcome>
  <enrollment type="Actual">303</enrollment>
  <condition>Fertility Monitor</condition>
  <condition>Cycle Tracking</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ava Fertility Tracker</intervention_name>
    <description>All women aged 18 to 40 years using Ava Fertility Tracker to track their cycles.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All women aged 18 to 40 years matching the eligibility criteria can be enrolled in the
        pilot study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged between 18 and 40 at the time of admission

          -  Not pregnant and no pregnancy wish during the pilot study period

          -  Have a regular sleep pattern (sleep at least four hours per night and not working
             nightshift)

          -  Have regular menstrual cycles

        Exclusion Criteria:

          -  Pregnant at study admission

          -  Currently breastfeeding or have breastfed in the past 6 months before study admission

          -  Currently using hormonal contraception or hormonal medication

          -  Health-related conditions that may affect menstrual cycle length and variability (e.g.
             PCOS, menopause, thyroid dysfunction)

          -  Unable to understand study instructions and/or not able to understand English or
             German

          -  More than one international overseas travel per month

          -  Unwilling to sign the ICF.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>ZEG Berlin</name>
      <address>
        <city>Berlin-Mitte</city>
        <state>Berlin</state>
        <zip>10115</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>August 5, 2019</study_first_submitted>
  <study_first_submitted_qc>August 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2019</study_first_posted>
  <last_update_submitted>February 11, 2020</last_update_submitted>
  <last_update_submitted_qc>February 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Center for Epidemiology and Health Research, Germany</investigator_affiliation>
    <investigator_full_name>Clare Barnett, MBBS (Hons) MPH</investigator_full_name>
    <investigator_title>Director of Project Management, Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

